全文获取类型
收费全文 | 20190篇 |
免费 | 1150篇 |
国内免费 | 72篇 |
专业分类
耳鼻咽喉 | 356篇 |
儿科学 | 653篇 |
妇产科学 | 597篇 |
基础医学 | 2809篇 |
口腔科学 | 1267篇 |
临床医学 | 1237篇 |
内科学 | 4485篇 |
皮肤病学 | 639篇 |
神经病学 | 1852篇 |
特种医学 | 536篇 |
外科学 | 3038篇 |
综合类 | 71篇 |
一般理论 | 4篇 |
预防医学 | 1428篇 |
眼科学 | 265篇 |
药学 | 1071篇 |
中国医学 | 110篇 |
肿瘤学 | 994篇 |
出版年
2023年 | 123篇 |
2022年 | 265篇 |
2021年 | 637篇 |
2020年 | 432篇 |
2019年 | 575篇 |
2018年 | 656篇 |
2017年 | 465篇 |
2016年 | 460篇 |
2015年 | 594篇 |
2014年 | 816篇 |
2013年 | 979篇 |
2012年 | 1451篇 |
2011年 | 1573篇 |
2010年 | 945篇 |
2009年 | 809篇 |
2008年 | 1346篇 |
2007年 | 1325篇 |
2006年 | 1286篇 |
2005年 | 1228篇 |
2004年 | 975篇 |
2003年 | 897篇 |
2002年 | 797篇 |
2001年 | 332篇 |
2000年 | 327篇 |
1999年 | 266篇 |
1998年 | 155篇 |
1997年 | 168篇 |
1996年 | 127篇 |
1995年 | 114篇 |
1994年 | 86篇 |
1993年 | 87篇 |
1992年 | 113篇 |
1991年 | 117篇 |
1990年 | 93篇 |
1989年 | 80篇 |
1988年 | 85篇 |
1987年 | 81篇 |
1986年 | 60篇 |
1985年 | 51篇 |
1984年 | 54篇 |
1983年 | 34篇 |
1982年 | 28篇 |
1981年 | 24篇 |
1980年 | 21篇 |
1979年 | 29篇 |
1977年 | 21篇 |
1975年 | 21篇 |
1974年 | 22篇 |
1970年 | 20篇 |
1969年 | 20篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
Luis A. Kluth Malte Rieken Evanguelos Xylinas Matthew Kent Michael Rink Morgan Rouprêt Nasim Sharifi Asha Jamzadeh Wassim Kassouf Dharam Kaushik Stephen A. Boorjian Florian Roghmann Joachim Noldus Alexandra Masson-Lecomte Dimitri Vordos Masaomi Ikeda Kazumasa Matsumoto Masayuki Hagiwara Eiji Kikuchi Yves Fradet Jonathan Izawa Ricardo Rendon Adrian Fairey Yair Lotan Alexander Bachmann Marc Zerbib Margit Fisch Douglas S. Scherr Andrew Vickers Shahrokh F. Shariat 《European urology》2014
Background
The impact of gender on the staging and prognosis of urothelial carcinoma of the bladder (UCB) is insufficiently understood.Objective
To assess gender-specific differences in pathologic factors and survival of UCB patients treated with radical cystectomy (RC).Design, setting, and participants
Data from 8102 patients treated with RC (6497 men [80%] and 1605 women [20%]) for UCB between 1971 and 2012 were analyzed.Outcome measurements and statistical analysis
Multivariable competing-risk regression analyses were performed to evaluate the relationship of gender on disease recurrence (DR) and cancer-specific mortality (CSM). We also tested the interaction of gender and tumor stage, nodal status, and lymphovascular invasion (LVI).Results and limitations
Female patients were older at the time of RC (p = 0.033) and had higher rates of pathologic stage T3/T4 disease (p < 0.001). In univariable, but not in multivariable analysis, female gender was associated with a higher risk of DR (p = 0.022 and p = 0.11, respectively). Female gender was an independent predictor for CSM (p = 0.004). We did not find a significant interaction between gender and stage, nodal metastasis, or LVI (all p values >0.05).Conclusions
We found female gender to be associated with a higher risk of CSM following RC. However, these findings do not appear to be explained by gender differences in pathologic stage, nodal status, or LVI. This gender disparity may be due to differences in care and/or the biology of UCB. 相似文献992.
F. R. Pruvot F. Navarro A. Janin M. Labalette E. Masy M. Lecomte-Houcke L. Gambiez M. C. Copin J. P. Dessaint 《Transplant international》1995,8(4):273-279
Quantification and localization of the main lymphocyte populations were studied in the livers of normal (n=8) and brain dead (n=8) subjects. Cytometric analysis performed on mononuclear cell suspensions obtained from liver biopsies was compared to an automatic image analysis of immunostained sections. The overall number of liver associated lymphocytes was in the usual range of peripheral blood content (2 to 9 · 109 cells). Phenotypic analysis showed predominant NK and CD8+ cells that highly expressed class II antigen and CD25 and CD69 activation markers. Quantitative mapping of these activated lymphocytes revealed their preferential localization in the portal tract and the perisinusoidal area as compared to the pericentrolobular zone, especially in donor livers. This strategic localization could suggest a possible early cooperation between donor lymphocytes and initial infiltrating cells from the recipient and could explain the special immunological status of allografted livers. 相似文献
993.
C. Santos A. López‐Doriga M. Navarro J. Mateo S. Biondo M. Martínez Villacampa G. Soler X. Sanjuan M. J. Paules B. Laquente E. Guinó E. Kreisler R. Frago J. R. Germà V. Moreno R. Salazar 《Colorectal disease》2013,15(4):414-422
Aim Adjuvant 5‐fluorouracil based chemotherapy has demonstrated benefit in Stage III colon cancer but still remains controversial in Stage II. The aim of this study was to analyse the prognostic impact of clinicopathological factors that may help guide treatment decisions in Stage II colon cancer. Method Between 1996 and 2006 data from patients diagnosed with colorectal cancer at Hospital Universitari Bellvitge and its referral comprehensive cancer centre Institut Català d′Oncologia/L’Hospitalet were prospectively included in a database. We identified 432 patients with Stage II colon cancer operated on at Hospital Universitari Bellvitge. The 5‐year relapse‐free survival (RFS) and colon‐cancer‐specific survival (CCSS) were determined. Results The 5‐year RFS and CCSS were 83% and 88%, respectively. Lymphovascular or perineural invasion was associated with RFS [hazard ratio (HR) 1.84; 95% CI 1.01–3.35]. Gender (women, HR 0.48; 95% CI 0.23–1) and lymphovascular or perineural invasion (HR 3.51; 95% CI 1.86–6.64) together with pT4 (HR 2.79; 95% CI 1.44–5.41) influenced CCSS. In multivariate analysis pT4 and lymphovascular or perineural invasion remained significantly associated with CCSS. We performed a risk index with these factors with prognostic impact. Patients with pT4 tumours and lymphovascular or perineural invasion had a 5‐year CCSS of 61%vs the 93% (HR 5.87; 95 CI 2.46–13.97) of those without any of these factors. Conclusion pT4 and lymphatic, venous or perineural invasion are confirmed as significant prognostic factors in Stage II colon cancer and should be taken into account in the clinical validation process of new molecular prognostic factors. 相似文献
994.
Zapata Julio César Restrepo Dominguez Gloria Inés Martínez Martínez-Sánchez Lina María de los Ángeles Rodríguez-Gázquez María García Juan Ricardo Gaviria Vásquez Andrea Urrego Ospina-Sánchez Juan Pablo Quintero Natalia Morales Restrepo Felipe Hernández Uribe Sol Beatriz Ochoa 《The Psychiatric quarterly》2020,91(1):183-190
Psychiatric Quarterly - To evaluate the level of adherence to antidepressant therapies and associated factors in patients with depressive disorders. a cross-sectional analytical study was conducted... 相似文献
995.
Daniel Reyes‐Haro María Alejandra González‐González Adriana Pétriz Abraham Rosas‐Arellano Helmut Kettenmann Ricardo Miledi Ataulfo Martínez‐Torres 《Journal of neuroscience research》2013,91(4):527-534
The ependymal glial cells (EGCs) from the periventricular zone of the cerebellum were studied to determine their distribution and the functional properties of their γ‐aminobutyric acid type A (GABAA) receptors. EGCs were identified by the presence of ciliated structures on their ventricular surface and their expression of glial fibrillary acidic protein (GFAP). Interestingly, diverse cell types, including neurons, astrocytes, and other types of glia, were identified in the subventricular zone by their current profiles. Electron microscopy showed ciliated cells and myelinated axons in this zone, but we found no collateral connections to suggest the presence of functional synapses. GABA‐mediated currents were recorded from EGCs in cerebellar slices from postnatal days 13 to 35 (PN13–PN35). These currents were blocked by TPMPA (a highly specific GABAAρ subunit antagonist) and bicuculline (a selective antagonist for classic GABAA receptors). Pentobarbital failed to modulate GABAA‐mediated currents despite the expression of GABAα1 and GABAγ2 subunits. In situ hybridization, RT‐PCR, and immunofluorescence studies confirmed GABAρ1 expression in EGCs of the cerebellum. We conclude that cerebellar EGCs express GABAρ1, which is functionally involved in GABAA receptor‐mediated responses that are unique among glial cells of the brain. © 2013 Wiley Periodicals, Inc. 相似文献
996.
997.
Ronny Cohen MD FACC Brooks Mirrer MD FACC Pablo Loarte MD Victor Navarro MD FACC 《Clinical cardiology》2013,36(1):6-9
Cardiac Teratoma is a tumor of very rare occurrence in adult population. Here we report a case in a Caucasian male with history of Human immunodeficiency virus infection where the symptom as presentation was recurrent episodes of tachycardia. The chest radiograph showed a lesion in the right heart border and subsequent investigation revealed an intrapericardial lesion, which was demonstrated to be a pericardial teratoma diagnosed by histopathology. In this case the initial differential diagnosis included lymphoma or an infectious organism as possible causes in a immunocompromised patient. Cardiac teratomas are among the less common types of cardiac tumors being more frequent in child population and around 1% of all the cardiac tumors in adults. Imaging studies are very helpful. CT and MRI are the best due to their resolution and ability to assess the relationship of the mass with the surrounding structures. Echocardiogram in also helpful determining the presence of pericardial effusion because cardiac teratomas are most of the time present in the pericardium. The final diagnosis is mostly made after surgical excision and this is the most effective treatment because they are relatively resistant to chemotherapy and radiotherapy. The authors have no funding, financial relationships, or conflicts of interest to disclose. 相似文献
998.
Carolina Cavaliéri Gomes Vanessa Fátima Bernardes Marina Gonçalves Diniz Luiz De Marco Ricardo Santiago Gomez 《BMC cancer》2012,12(1):61
Background
Development of accurate therapeutic approaches to salivary gland neoplasms depends on better understanding of their molecular pathogenesis. Tumour growth is regulated by the balance between proliferation and apoptosis. Few studies have investigated apoptosis in salivary tumours relying almost exclusively on immunohistochemistry or TUNEL assay. Furthermore, there is no information regarding the mRNA expression profile of apoptotic genes in salivary tumors. Our objective was to investigate the quantitative expression of BCL-2 (anti-apoptotic), BAX and Caspase3 (pro-apoptotic genes) mRNAs in salivary gland neoplasms and examine the association of these data with tumour size, proliferative activity and p53 staining (parameters associated with a poor prognosis of salivary tumours patients). 相似文献999.
1000.
Andrés Munyo-Estefan Matías López-Paullier Rogelio Charlone-Granucci Juan L. Peña-Rehbein Ricardo d′Albora-Rivas Luis Schiavo-Viviani 《Acta otorrinolaringologica espanola》2009,60(4):268-271
IntroductionThe aim of this study is to determine whether the incidence of hypothyroidism in patients with Head and Neck Cancer who have undergone neck radiotherapy justifies the inclusion of thyroid function monitoring in the pre-operative and follow-up evaluation protocols.Material and methodsA retrospective study was conducted with all the patients seen in the Oncology Section of the Otorhinolaryngology Department in the “Hospital de Clínicas”, Montevideo, Uruguay, from January 1970 to May 2008. A total of 550 case records were analyzed. Of the 550 patients, 188 were excluded due to the fact they had not received radiotherapy as part of their treatment and 362 were included in the study. Of these, 55 patients had thyroid stimulating hormone (TSH) level determination after treatment with radiation therapy. Hypothyroidism was defined as a TSH value greater than or equal to 4.5 mIU/L, regardless of whether or not any symptoms were presented.Results36.4% of the patients were diagnosed as having clinical or sub-clinical hypothyroidism. The type of treatment carried out, particularly whether or not surgical resection was performed, was found to be the most significant predictive factor for the development of hypothyroidism (P=0.054).ConclusionMonitoring of the thyroid function on a six-month or annual basis, at least during the first 5 post-treatment years, has to be included in the follow-up and control protocols of every patient undergoing neck RT, and patients with TSH values over 4.5 mIU/L should be referred to the endocrinologist for hormone replacement, whether they present symptoms or not. 相似文献